Nanomedical system for nucleic acid drugs created with the biodegradable nanoparticle platform

References

• Alshamsan A, Haddadi A, Hamdy S, Samuel J, El-Kadi A, Uludag H, Lavasanifar A. STAT3 silencing in dendritic cells by siRNA polyplexes encapsulated in PLGA nanoparticles for the modulation of anti-cancer immune response. Mol Pharmaceutics 2010; 7: 1643–54
   PubMed Web of Science ®Google Scholar
• Andersen MØ, Lichawska A, Arpanaei A, Rask Jensen SM, Kaur H, Oupicky D, Besenbacher F, Kingshott P, Kjems J, Howard KA. Surface functionalisation of PLGA nanoparticles for gene silencing. Biomaterials 2010; 31: 5671–7
   PubMed Web of Science ®Google Scholar
• Aouadi M, Tesz GJ, Nicoloro SM, Wang M, Chouinard M, Soto E, Ostroff GR, Czech MP. Orally delivered siRNA targeting macrophage Map4k4 suppresses systemic inflammation. Nature 2009; 458: 1180–4
   PubMed Web of Science ®Google Scholar
• Baoum A, Dhillon N, Buch S, Berkland C. Cationic surface modification of PLG nanoparticles offers sustained gene delivery to pulmonary epithelial cells. J Pharm Sci 2010; 99: 2413–22
   PubMed Web of Science ®Google Scholar
• Basarkar A, Devineni D, Palaniappan R, Singh J. Preparation, characterization, cytotoxicity and transfection efficiency of poly(D-L-lactide-co-glycolide) and poly(D-L-lactic acid) cationic nanoparticles for controlled delivery of plasmid DNA. Int J Pharm 2007; 343: 247–54
   PubMed Web of Science ®Google Scholar
• Belbella A, Vauthier C, Fessi H, Devissaguet J-P, Puisieux F. In vitro degradation of nanospheres from poly(D,L-lactides) of different molecular weights and polydispersities. Int J Pharm 1996; 129: 95–102
   Web of Science ®Google Scholar
• Bhavsar M, Amiji M. Gastrointestinal distribution and in vivo gene transfection studies with nanoparticles-in-microsphere oral system (NiMOS). J Controlled Release 2007; 119: 339–48
   PubMed Web of Science ®Google Scholar
• Cartiera MS, Johnson KM, Rajendran V, Caplan MJ, Saltzman WM. The uptake and intracellular fate of PLGA nanoparticles in epithelial cells. Biomaterials 2009; 30: 2790–8
   PubMed Web of Science ®Google Scholar
• Chasin M, Langer R, (eds.) 1990. Biodegradable polymers as drug delivery systems, drugs and pharmaceutical sciences. New York, NY: Marcel Dekker
   Google Scholar
• Cohen H, Levy R, Gao J, Fishbein I, Kousaev V, Sosnowski S, Slomkowski S, Golomb G. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gene Ther 2000; 7: 1896–905
   PubMed Web of Science ®Google Scholar
• Couvreur P, Puisieux F. Nano- and microparticles for the delivery of polypeptides and proteins. Adv Drug Delivery Rev 1993; 10: 141–62
   Web of Science ®Google Scholar
• Cun D, Foged C, Yang M, Frøkjær S, Nielsen HM. Preparation and characterization of poly(dl-lactide-co-glycolide) nanoparticles for siRNA delivery. Int J Pharm 2010; 390: 70–5
   PubMed Web of Science ®Google Scholar
• Cun D, Jensen DK, Maltesen MJ, Bunker M, Whiteside P, Scurr D, Foged C, Nielsen HM. High loading efficiency and sustained release of siRNA encapsulated in PLGA nanoparticles: Quality by design optimization and characterization. Eur J Pharm Biopharm 2011; 77: 26–35
   PubMed Web of Science ®Google Scholar
• De Vry CG, Prasad S, Komuves L, Lorenzana C, Parham C, Le T, Adda S, Hoffman J, Kahoud N, Garlapati R, et al. Non-viral delivery of nuclear factor-kappaB decoy ameliorates murine inflammatory bowel disease and restores tissue homeostasis. Gut 2007; 56: 524–33
   PubMed Web of Science ®Google Scholar
• Elbashir SM, Harborth J, Lendeckel W, Yalcin A, Weber K, Tuschl T. Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 2001; 411: 494–8
   PubMed Web of Science ®Google Scholar
• Fichtner-Feigl S, Fuss IJ, Preiss JC, Strober W, Kitani A. Treatment of murine Th1- and Th2-mediated inflammatory bowel disease with NF-kappa B decoy oligonucleotides. J Clin Invest 2005; 115: 3057–71
   PubMed Web of Science ®Google Scholar
• Jain R. The manufacturing techniques of various drug loaded biodegradable poly (lactide-co-glycolide)(PLGA) devices. Biomaterials 2000; 21: 2475–90
   PubMed Web of Science ®Google Scholar
• Jain A, Chasoo G, Singh SK, Saxena AK, Jain SK. Transferrin-appended PEGylated nanoparticles for temozolomide delivery to brain: In vitrocharacterisation. J Microencapsul 2011; 28: 21–8
   PubMed Web of Science ®Google Scholar
• Katas H, Cevher E, Alpar HO. Preparation of polyethyleneimine incorporated poly(D,L-lactide-co-glycolide) nanoparticles by spontaneous emulsion diffusion method for small interfering RNA delivery. Int J Pharm 2009; 369: 144–54
   PubMed Web of Science ®Google Scholar
• Kawashima Y, Yamamoto H, Takeuchi H, Hino T, Niwa T. Properties of a peptide containing dl-lactide/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods. Eur J Pharm Biopharm 1998; 45: 41–8
   PubMed Web of Science ®Google Scholar
• Kim SH, Jeong JH, Chun KW, Park TG. Target-specific cellular uptake of PLGA nanoparticles coated with poly(L-lysine)-poly(ethylene glycol)-folate conjugate. Langmuir 2005b; 21: 8852–7
   PubMed Web of Science ®Google Scholar
• Kim I, -S, Lee S-K, Park Y-M, Lee Y-B, Shin S-C, Lee KC, Oh I, -J. Physicochemical characterization of poly(l-lactic acid) and poly(D,L-lactide-co-glycolide) nanoparticles with polyethylenimine as gene delivery carrier. Int J Pharm 2005a; 298: 255–62
   PubMed Web of Science ®Google Scholar
• Kreuter J. Peroral administration of nanoparticles. Adv Drug Delivery Rev 1991; 7: 71–86
   Web of Science ®Google Scholar
• Kriegel C, Amiji M. Oral TNF-α gene silencing using a polymeric microsphere-based delivery system for the treatment of inflammatory bowel disease. J Controlled Release 2010; 150: 77–86
   PubMed Web of Science ®Google Scholar
• Kumari A, Yadav SK. Cellular interactions of therapeutically delivered nanoparticles. Expert Opin Drug Deliv 2011; 8: 141–51
   PubMed Web of Science ®Google Scholar
• Kumari A, Yadav SK, Yadav SC. Biodegradable polymeric nanoparticles based drug delivery systems. Colloids Surf B 2010; 75: 1–18
   PubMed Web of Science ®Google Scholar
• Lambert G, Fattal E, Pinto-Alphandary H, Gulik A, Couvreur P. Polyisobutylcyanoacrylate nanocapsules containing an aqueous core for the delivery of oligonucleotides. Int J Pharm 2001; 214: 13–16
   PubMed Web of Science ®Google Scholar
• Mo Y, Lim LY. Mechanistic study of the uptake of wheat germ agglutinin-conjugated PLGA nanoparticles by A549 cells. J Pharm Sci 2004; 93: 20–8
   PubMed Web of Science ®Google Scholar
• Mo Y, Lim LY. Paclitaxel-loaded PLGA nanoparticles: Potentiation of anticancer activity by surface conjugation with wheat germ agglutinin. J Controlled Release 2005; 108: 244–62
   PubMed Web of Science ®Google Scholar
• Moret I, Esteban Peris J, Guillem VM, Benet M, Revert F, Dasi F, Crespo A, Aliño SF. Stability of PEI-DNA and DOTAP-DNA complexes: Effect of alkaline pH, heparin and serum. J Controlled Release 2001; 76: 169–81
   PubMed Web of Science ®Google Scholar
• Morishita R, Sugimoto T, Aoki M, Kida I, Tomita N, Moriguchi A, Maeda K, Sawa Y, Kaneda Y, Higaki J, et al. In vivo transfection of cis element "decoy" against nuclear factor-kappaB binding site prevents myocardial infarction. Nat Med 1997; 3: 894–9
   PubMed Web of Science ®Google Scholar
• Morishita R, Tomita N, Kaneda Y, Ogihara T. Molecular therapy to inhibit NFκB activation by transcription factor decoy oligonucleotides. Curr Opin Pharmacol 2004; 4: 139–46
   PubMed Web of Science ®Google Scholar
• Murakami H, Kobayashi M, Takeuchi H, Kawashima Y. Preparation of poly(-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. Int J Pharm 1999; 187: 143–52
   PubMed Web of Science ®Google Scholar
• Niven R, Zhang Y, Smith J. Toward development of a non-viral gene therapeutic. Adv Drug Deliv Rev 1997; 26: 135–50
   PubMed Web of Science ®Google Scholar
• Niwa T, Takeuchi H, Hino T, Kunou N, Kawashima Y. Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D,L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method, and the drug release behavior. J Controlled Release 1993; 25: 89–98
   Web of Science ®Google Scholar
• Owensiii D, Peppas N. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. Int J Pharm 2006; 307: 93–102
   PubMedGoogle Scholar
• Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003a; 55: 329–47
   PubMed Web of Science ®Google Scholar
• Panyam J, Labhasetwar V. Dynamics of endocytosis and exocytosis of poly(D,L-lactide-co-glycolide) nanoparticles in vascular smooth muscle cells. Pharm Res 2003b; 20: 212–20
   PubMed Web of Science ®Google Scholar
• Panyam J, Zhou WZ, Prabha S, Sahoo SK, Labhasetwar V. Rapid endo-lysosomal escape of poly(DL-lactide-co-glycolide) nanoparticles: Implications for drug and gene delivery. FASEB J 2002; 16: 1217–26
   PubMed Web of Science ®Google Scholar
• Patil Y, Panyam J. Polymeric nanoparticles for siRNA delivery and gene silencing. Int J Pharm 2009; 367: 195–203
   PubMed Web of Science ®Google Scholar
• Prabha S, Zhou W-Z, Panyam J, Labhasetwar V. Size-dependency of nanoparticle-mediated gene transfection: Studies with fractionated nanoparticles. Int J Pharm 2002; 244: 105–15
   PubMed Web of Science ®Google Scholar
• Qaddoumi MG, Ueda H, Yang J, Davda J, Labhasetwar V, Lee VHL. The characteristics and mechanisms of uptake of PLGA nanoparticles in rabbit conjunctival epithelial cell layers. Pharm Res 2004; 21: 641–8
   PubMed Web of Science ®Google Scholar
• Roy K, Mao HQ, Huang SK, Leong KW. Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 1999; 5: 387–91
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Labhasetwar V. Enhanced antiproliferative activity of transferrin-conjugated paclitaxel-loaded nanoparticles is mediated via sustained intracellular drug retention. Mol. Pharm 2005; 2: 373–83
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly (D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Controlled Release 2002; 82: 105–14
   PubMed Web of Science ®Google Scholar
• Sneh-Edri H, Stepensky D. ‘IntraCell’ plugin for assessment of intracellular localization of nano-delivery systems and their targeting to the individual organelles. Biochem Biophys Res Commun 2011; 405: 228–33
   PubMed Web of Science ®Google Scholar
• Soppimath KS, Aminabhavi TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticles as drug delivery devices. J Controlled Release 2001; 70: 1–20
   PubMed Web of Science ®Google Scholar
• Spenlehauer G, Vert M, Benoit JP, Boddaert A. In vitro and in vivo degradation of poly(D,L lactide/glycolide) type microspheres made by solvent evaporation method. Biomaterials 1989; 10: 557–63
   PubMed Web of Science ®Google Scholar
• Sun S, Liang N, Piao H, Yamamoto H, Kawashima Y, Cui F. Insulin-S.O (sodium oleate) complex-loaded PLGA nanoparticles: Formulation, characterization and in vivo evaluation. J Microencapsul 2010; 27: 471–8
   PubMed Web of Science ®Google Scholar
• Tahara K, Furukawa S, Yamamoto H, Kawashima Y. Hybrid-modified poly(D,L-lactide-co-glycolide) nanospheres for a novel cellular drug delivery system. Int J Pharm 2010a; 392: 311–13
   PubMed Web of Science ®Google Scholar
• Tahara K, Kato Y, Yamamoto H, Kreuter J, Kawashima Y. Intracellular drug delivery using polysorbate 80-modified poly(D,L-lactide-co-glycolide) nanospheres to glioblastoma cells. J Microencapsul 2011a; 28: 29–36
   PubMed Web of Science ®Google Scholar
• Tahara K, Sakai T, Yamamoto H, Takeuchi H, Hirashima N, Kawashima Y. Improved cellular uptake of chitosan-modified PLGA nanospheres by A549 cells. Int J Pharm 2009; 382: 198–204
   PubMed Web of Science ®Google Scholar
• Tahara K, Sakai T, Yamamoto H, Takeuchi H, Hirashima N, Kawashima Y. Improvements in transfection efficiency with chitosan modified PLGA nanospheres prepared by the emulsion solvent diffusion method, for gene delivery. Chem Pharm Bull (Tokyo) 2011b; 59: 1–6
   PubMed Web of Science ®Google Scholar
• Tahara K, Sakai T, Yamamoto H, Takeuchi H, Kawashima Y. Establishing chitosan coated PLGA nanosphere platform loaded with wide variety of nucleic acid by complexation with cationic compound for gene delivery. Int J Pharm 2008; 354: 210–6
   PubMed Web of Science ®Google Scholar
• Tahara K, Samura S, Tsuji K, Yamamoto H, Tsukada Y, Bando Y, Tsujimoto H, Morishita R, Kawashima Y. Oral nuclear factor-kappaB decoy oligonucleotides delivery system with chitosan modified poly(D,L-lactide-co-glycolide) nanospheres for inflammatory bowel disease. Biomaterials 2011c; 32: 870–8
   PubMed Web of Science ®Google Scholar
• Tahara K, Yamamoto H, Hirashima N, Kawashima Y. Chitosan-modified poly(D,L-lactide-co-glycolide) nanospheres for improving siRNA delivery and gene-silencing effects. Eur J Pharm Biopharm 2010b; 74: 421–6
   PubMed Web of Science ®Google Scholar
• Tahara K, Yamamoto H, Kawashima Y. Cellular uptake mechanisms and intracellular distributions of polysorbate 80-modified poly (D,L-lactide-co-glycolide) nanospheres for gene delivery. Eur J Pharm Biopharm 2010c; 75: 218–24
   PubMed Web of Science ®Google Scholar
• Takeuchi H, Yamamoto H, Kawashima Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv Drug Delivery Rev 2001; 47: 39–54
   PubMed Web of Science ®Google Scholar
• Vauthier C, Dubernet C, Fattal E, Pinto-Alphandary H, Couvreur P. Poly(alkylcyanoacrylates) as biodegradable materials for biomedical applications. Adv Drug Delivery Rev 2003; 55: 519–48
   PubMed Web of Science ®Google Scholar
• Wang D, Robinson DR, Kwon GS, Samuel J. Encapsulation of plasmid DNA in biodegradable poly(D, L-lactic-co-glycolic acid) microspheres as a novel approach for immunogene delivery. J Controlled Release 1999; 57: 9–18
   PubMed Web of Science ®Google Scholar
• Weissenbock A, Wirth M, Gabor F. WGA-grafted PLGA-nanospheres: Preparation and association with Caco-2 single cells. J Controlled Release 2004; 99: 383–92
   PubMed Web of Science ®Google Scholar
• Wilson DS, Dalmasso G, Wang L, Sitaraman SV, Merlin D, Murthy N. Orally delivered thioketal nanoparticles loaded with TNF-α-siRNA target inflammation and inhibit gene expression in the intestines. Nat Mater 2010; 9: 923–8
   PubMed Web of Science ®Google Scholar
• Woodrow KA, Cu Y, Booth CJ, Saucier-Sawyer JK, Wood MJ, Saltzman WM. Intravaginal gene silencing using biodegradable polymer nanoparticles densely loaded with small-interfering RNA. Nat Mater 2009; 8: 526–33
   PubMed Web of Science ®Google Scholar
• Xiang JY, Wu LG, Huang XL, Zhang M, Pen L, Ouyan Q, Gan HT. Amelioration of murine dextran sulfate sodium-induced colitis by nuclear factor-κb decoy oligonucleotides. Am J Surg 2009; 197: 797–805
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Kuno Y, Sugimoto S, Takeuchi H, Kawashima Y. Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions. J Controlled Release 2005; 102: 373–81
   PubMed Web of Science ®Google Scholar
• Yuan X, Shah BA, Kotadia NK, Li J, Gu H, Wu Z. The development and mechanism studies of cationic chitosan-modified biodegradable PLGA nanoparticles for efficient siRNA drug delivery. Pharm Res 2010; 27: 1285–95
   PubMed Web of Science ®Google Scholar
• Zhang Z, Huey Lee S, Feng S-S. Folate-decorated poly(lactide-co-glycolide)-vitamin E TPGS nanoparticles for targeted drug delivery. Biomaterials 2007; 28: 1889–99
   PubMed Web of Science ®Google Scholar